amlodipine besylate and olmesartan medoxomil
amlodipine besylate and olmesartan medoxomil is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: amlodipine besylate and olmesartan medoxomil; Generic name: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL; Manufacturer: Golden State Medical Supply, Inc..
| Brand name | amlodipine besylate and olmesartan medoxomil |
|---|---|
| Generic name | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL |
| Manufacturer | Golden State Medical Supply, Inc. |
| Used for | 1 INDICATIONS AND USAGE Amlodipine besylate and olmesartan medoxomil is indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with amlodipine besylate and olmesartan medoxomil. Control of high blood pressure should be part of comprehensive cardiovascular risk |
| Dosage | 2 DOSAGE AND ADMINISTRATION The usual starting dose of amlodipine besylate and olmesartan medoxomil is 5/20 mg once daily. The dosage can be increased after 1 to 2 weeks of therapy to a maximum dose of one 10/40 mg tablet once daily as needed to control blood pressure [ s ee Clinical Studies ( 14.1 )] . Recommended starting dose: 5/20 mg once daily ( 2 ). Titrate as needed in two-week intervals up to a maximum of 10/40 mg once daily ( 2 ). |
| Warnings | WARNING: FETAL TOXICITY When pregnancy is detected, discontinue amlodipine besylate and olmesartan medoxomil as soon as possible ( 5.1 , 8.1 ). Drugs that act directly on the renin-angiotensin system (RAS) can cause injury and death to the developing fetus ( 5.1 , 8.1 ). WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue amlodipine besylate and olmesartan medoxomil as soon as possible ( 5.1 , 8.1 ). Drugs that act directly |
| Active ingredient(s) | AMLODIPINE BESYLATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=132cca8f-48a2-2516-e063-6394a90a5f32 |